Overview
- Q2 returns were strong and highly concentrated in AI infrastructure and semiconductor beneficiaries according to multiple mid‑August investor letters, with indexes recording their best quarter since 2020.
- Portfolio managers reported trimming or selling large winners to manage position size and taking profits in names such as Corning and other data‑center plays to reduce crowding.
- Baron highlighted Tesla’s improving autonomy metrics, scaling Cybercab robotaxi production and the design of a next‑generation inference chip that support the firm’s long‑term AI thesis.
- Aristotle and other managers pointed to company‑specific catalysts reshaping stock outlooks, including FDA approval and guideline inclusion for Guardant’s tests and concern about slowing growth at device and EDA franchises like Boston Scientific and Synopsys.
- Funds warned of competitive and valuation risks for AI leaders, noting that hyperscalers’ internal chip programs and rising supply could erode margins for dominant suppliers such as NVIDIA, while litigation and regulatory events at firms like Burford could produce material near‑term outcomes.